Features Pricing Learn Reverse Splits Tracker Shelf & ATM Tracker Warrant Tracker PIPE Deal Tracker Weekly Report FAQ API Sign In →
56 /100
HIGH RISK
Score updated Aug 28, 2026

LTRN — Lantern Pharma Inc. Dilution Risk Tracker

Track LTRN dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track LTRN — Get alerts when the score changes →

As of August 28, 2026, Lantern Pharma Inc. (LTRN) has a DilutionWatch DilutionScore of 56/100, rated HIGH dilution risk. Lantern Pharma Inc. has a market capitalization of $45.80M, 12.78M shares outstanding, 32 institutional holders tracked. Stored dilution-related fields include 86.7K outstanding warrants.

This page includes automatically generated factual summaries from DilutionWatch data. It is not financial advice, not investment research, and not a recommendation. Do your own research. Read the full disclaimer and terms of service.

Score Breakdown

📋 Offering Ability
40
💰 Cash Runway
85
📊 Float Risk
30
⚠️ Warrant Exposure
15
🔄 Convertible Debt
40

Dilution Forecast

Watch
Minor dilution signals detected
model est. 22%
💰 Capital Raise model 35%
• Low cash runway: 6 months remaining
🔄 Reverse Split model est. 15%
• Only 6 months cash — financial pressure
🔔 Track LTRN — Get forecast alerts →

Market Data

Market Cap$45.80M
Shares Outstanding12.78M
Float8.61M
Cash$7.36M
Debt$59.1K
Short InterestN/A

Institutional Holdings

QoQ: ↑ 2.8% shares (2026Q1 vs prior)
32 institutional holders · 2.40M shares
#1 BIOS Capital Management, LP 864.4K shares
#2 VANGUARD CAPITAL MANAGEMENT LLC 664.2K shares
#3 CM Management, LLC 250.0K shares
+ 17 more holders Sign up free to view →

Institutional holder totals are aggregated from ownership filings and may use a different share basis or reporting date than public float. They are not a reconciliation against tradeable float.

Short Interest

Short Interest846.4K
Days to Cover10.1
% of Float9.8%
FINRA data as of Jul 31, 2026

Recent SEC Activity

xbrl XBRL WARRANT 2026-06-30
Full SEC filing analysis available with free account

Recent News

No recent news

Factual LTRN Dilution Snapshot

Lantern Pharma Inc. (LTRN) has a DilutionScore of 56/100, rated High dilution risk. Score date: August 28, 2026.

This automatically generated snapshot is assembled from stored DilutionWatch data fields and may contain data-source errors or omissions. It is not financial advice, not investment research, and not a recommendation. Do your own research and review the full disclaimer and terms of service.

Track LTRN Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking LTRN — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required

Related Stocks — HIGH Risk

Other HIGH dilution risk stocks tracked by DilutionWatch with similar profiles:

→ Biotech / Pharma sector dilution risk overview

Browse all 8,024+ tracked stocks →

📖 Dilution Education
→ Complete Dilution Guide for Retail Investors → Anti-Dilution Provisions Explained → Stock Dilution Red Flags to Watch → Understanding Shelf Registrations
More Research for LTRN
LTRN FDA Catalyst Timeline & Biotech Grade — BiotechSigns

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.